Results 181 to 190 of about 40,504 (198)

Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV

New England Journal of Medicine, 2006
Jeffrey Enejosa
exaly  

Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients with Human Immunodeficiency Virus Infection

New England Journal of Medicine, 2003
Esteban Martinez, David Dalmau, Esteban Ribera   +2 more
exaly  

Efavirenz: effective against HIV-1, but who can afford to benefit?

Lancet, The, 2000
Khabir Ahmad
exaly  

Neuronal toxicity of efavirenz: a systematic review

Expert Opinion on Drug Safety, 2013
Gary Maartens, Eric H Decloedt
exaly  

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

Lancet, The, 2004
exaly  

Efavirenz: a review

Expert Opinion on Pharmacotherapy, 2007
Ferdinand Wnm Wit
exaly  

Efavirenz

Reactions Weekly, 2014
openaire   +1 more source

Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial

Lancet, The, 2014
exaly  

Efavirenz

Reactions Weekly, 2023
openaire   +1 more source

Pharmacokinetic Interactions Between Efavirenz and Rifampicin in HIV-Infected Patients with Tuberculosis

Clinical Pharmacokinetics, 2012
Eva Maria Leon Jimenez, Jeronimo Pachon
exaly